1 – 5 of 14
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity
(
- Contribution to journal › Article
- 2021
-
Mark
Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset
(
- Contribution to journal › Article
-
Mark
Comparison of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria With Two Sets of Earlier Systemic Lupus Erythematosus Classification Criteria
(
- Contribution to journal › Article
- 2020
-
Mark
Guidelines of the international writing group on the diabetic foot on diagnosis
(
- Contribution to journal › Article
- 2016
-
Mark
Blockade of Tim-1 and Tim-4 enhances atherosclerosis in low-density lipoprotein receptor-deficient mice
(
- Contribution to journal › Article